Molecular analysis of COVID-19’s powerful second wave in Houston shows a mutated virus strain linked to higher transmission and infection rates than the coronavirus strains that caused Houston’s first wave. Gene sequencing results from 5,085...
23-Sep-2020 4:55 PM EDT Add to Favorites
A study released by Houston Methodist Sept. 10 in the Journal of Clinical Investigation takes researchers closer to developing a uniform, universal COVID-19 antibody test. The multicenter collaboration tested alternative ways to measure COVID-19...
8-Sep-2020 4:00 PM EDT Add to Favorites
A preliminary analysis of an ongoing study of more than 300 COVID-19 patients treated with convalescent plasma therapy at Houston Methodist suggests the treatment is safe and effective. The results, published in The American Journal of Pathology,...
12-Aug-2020 6:30 PM EDT Add to Favorites
The first convalescent plasma transfusion trial results from Houston Methodist have been published. Of the study’s 25 patients, 19 have improved and 11 discharged. With no adverse side effects caused by the therapy, the study concluded...
7-Jun-2020 10:05 PM EDT Add to Favorites
COVID-19 has caused social isolation, a disruption in routine and a fear in many that they will catch the virus. This type of sudden change can induce stress and anxiety. However, Houston Methodist psychologist, William Orme, Ph.D., says there are...
27-May-2020 10:55 AM EDT Add to Favorites
The first convalescent plasma transfusion trial results from Houston Methodist have been released. Of the 25 patients in the study, 19 have improved and 11 have been discharged. With no adverse side effects caused by the therapy, the study concluded...
13-May-2020 12:05 PM EDT Add to Favorites
Houston Methodist released gene sequencing results from the first strains of the virus causing COVID-19 disease in Houston. Results reveal multiple introductions of SARS-CoV-2 into Houston followed by rapid community spread. No evidence was found of...
8-May-2020 2:40 PM EDT Add to Favorites
COVID-19 patients in a clinical trial at Houston Methodist Hospital are responding quickly to the antiviral drug Remdesivir. Sponsored by Gilead Sciences, Houston Methodist was the fifth site in the U.S. to join the trials and the only trial site in...
17-Apr-2020 6:05 PM EDT Add to Favorites
See All News
Houston Methodist oncologist available to comment on NCI model predicting 10,000 additional breast/colorectal cancer deaths due to COVID-19
24-Jun-2020 10:10 AM EDT
Necessity being the mother of invention, Houston Methodist clinicians, researchers and staff have collaborated on a number of clinical device and research innovations in response to COVID-19. Houston Methodist Academic Institute leadership has...
29-Apr-2020 12:10 PM EDT
Bita Kash, PhD, Researcher with Houston Methodist, available to discuss COVID-19 and African American communities
20-Apr-2020 2:30 PM EDT
8-Jan-2020 3:00 PM EST
10-Dec-2019 4:05 PM EST
Six tips for avoiding holiday headache triggers from Houston Methodist neurologist Bing Liao, M.D., M.Sc.
21-Nov-2019 12:05 PM EST
Nearly 25% of women live with treatable conditions known as pelvic floor disorders, but there is one main reason why the vast majority of them will not seek treatment: they are too embarrassed to talk about it.
20-Nov-2019 11:20 AM EST
More than one-third of Americans get less than seven hours of sleep each night, putting them at risk for serious, chronic health conditions such as diabetes, heart disease and obesity. The real victim of a lack of sleep, however, is the brain.
29-Oct-2019 2:15 PM EDT